Hormone replacement therapy and Haematocrit decreased

Summary:

Haematocrit decreased is found among people with Hormone replacement therapy, especially for people who are female, 50-59 old.

The study analyzes which people have Haematocrit decreased with Hormone replacement therapy. It is created by eHealthMe based on reports of 49 people who have Hormone replacement therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hormone replacement therapy?

Hormone replacement therapy is found to be associated with 10 drugs and 98 conditions by eHealthMe. Check the latest studies of Hormone replacement therapy.

What is Haematocrit decreased?

Haematocrit decreased is found to be associated with 1,639 drugs and 2,394 conditions by eHealthMe. Check the latest studies of Haematocrit decreased.

On Jul, 15, 2026

49 people who have Hormone Replacement Therapy and Haematocrit Decreased are studied.

Would you have Haematocrit decreased when you have Hormone replacement therapy?

Gender of people who have Hormone Replacement Therapy and experienced Haematocrit Decreased *:

female: 100 %
male: 0.0 %

Age of people who have Hormone Replacement Therapy and experienced Haematocrit Decreased *:

Common co-existing conditions for these people *:

High Blood Pressure: 14 people, 28.57%
Breast Cancer: 11 people, 22.45%
Pain: 8 people, 16.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 16.33%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 14.29%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 14.29%
Hepatitis C: 5 people, 10.20%
Breast Cancer Metastatic: 5 people, 10.20%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 10.20%
Metastases To Bone (cancer spreads to bone): 4 people, 8.16%

Common drugs taken by these people *:

Common symptoms for these people *:

Haemoglobin Decreased: 33 people, 67.35%
Red Blood Cell Count Decreased: 22 people, 44.90%
Back Pain: 20 people, 40.82%
Headache (pain in head): 19 people, 38.78%
Nausea (feeling of having an urge to vomit): 17 people, 34.69%
Fatigue (feeling of tiredness): 17 people, 34.69%
Thrombocytopenia (decrease of platelets in blood): 17 people, 34.69%
White Blood Cell Count Decreased: 13 people, 26.53%
Dizziness: 12 people, 24.49%
Nausea And Vomiting: 12 people, 24.49%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit decreased?

- Check whether Haematocrit decreased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit decreased and Hormone replacement therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.